Education
About Us
Working with TipRanks
Follow Us
Peptidream Inc. (PPTDF)
OTHER OTC:PPTDF
PPTDF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.00 - $22.34
Previous CloseN/A
Volume10.00
Average Volume (3M)319.00
Market Cap
$1.46B
Enterprise Value$198.19B
Total Cash (Recent Filing)$33.33B
Total Debt (Recent Filing)$18.98B
Price to Earnings (P/E)15.5
Beta0.65
Next Earnings
Nov 06, 2025EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding130,010,400
10 Day Avg. Volume130
30 Day Avg. Volume319
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap135.45
Enterprise Value/Revenue10.38
Enterprise Value/Gross Profit25.71
Enterprise Value/Ebitda-51.76
Forecast
1Y Price Target
$10.14Price Target Upside-14.14% Downside
Rating ConsensusHold
Number of Analyst Covering0
Peptidream News
PPTDF FAQ
What was Peptidream Inc.’s price range in the past 12 months?
Peptidream Inc. lowest stock price was $10.00 and its highest was $22.34 in the past 12 months.
What is Peptidream Inc.’s market cap?
Peptidream Inc.’s market cap is $1.46B.
When is Peptidream Inc.’s upcoming earnings report date?
Peptidream Inc.’s upcoming earnings report date is Nov 06, 2025 which is in 43 days.
How were Peptidream Inc.’s earnings last quarter?
Peptidream Inc. released its earnings results on Aug 07, 2025. The company reported -$0.057 earnings per share for the quarter, missing the consensus estimate of $0.069 by -$0.127.
Is Peptidream Inc. overvalued?
According to Wall Street analysts Peptidream Inc.’s price is currently Overvalued.
Does Peptidream Inc. pay dividends?
Peptidream Inc. does not currently pay dividends.
What is Peptidream Inc.’s EPS estimate?
Peptidream Inc.’s EPS estimate is 0.22.
How many shares outstanding does Peptidream Inc. have?
Peptidream Inc. has 130,010,400 shares outstanding.
What happened to Peptidream Inc.’s price movement after its last earnings report?
Peptidream Inc. reported an EPS of -$0.057 in its last earnings report, missing expectations of $0.069. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Peptidream Inc.?
Currently, no hedge funds are holding shares in PPTDF
Company Description
Peptidream Inc.
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
PPTDF Company Deck
PPTDF Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook for the company with strong financial performance and promising pipeline developments, despite some challenges in specific segments and uncertainties in deal closures.View all PPTDF earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
2.65% Mutual Funds
― Other Institutional Investors
93.68% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---